G1 Therapeutics
0 sources
G1 Therapeutics
Summary
G1 Therapeutics is a company[1]. It draws 26 Wikipedia views per month (company category, ranking #299 of 2,787).[2]
Key Facts
- G1 Therapeutics is in the country of US[3].
- G1 Therapeutics's instance of is recorded as company[4].
- G1 Therapeutics's product or material produced is recorded as trilaciclib[5].
- G1 Therapeutics's legal form is recorded as 8888[6].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 529900TC35UPZQYRKW13[7]
-
Registered legal name: G1 Therapeutics Inc.[8]
-
Legal jurisdiction: US-DE[9]
-
GLEIF entity category: GENERAL[10]
-
Legal form (ISO 20275 ELF): 8888[11]
-
Other legal form: Corporation[12]
-
Entity status: ACTIVE[13]
-
LEI registration status: LAPSED[14]
-
LEI first registered: 2018-10-10[15]
-
LEI last updated: 2021-07-19[16]
-
LEI next renewal: 2019-10-10[17]
-
Managing LOU: 5299000J2N45DDNE4Y28[18]
-
Registration authority: RA000602[19]
-
Authority entity ID: 4549681[20]
-
Conformity flag: NON_CONFORMING[21]
Body
Ownership
G1 Therapeutics's product or material produced is recorded as trilaciclib[5].
Why It Matters
G1 Therapeutics draws 26 Wikipedia views per month (company category, ranking #299 of 2,787).[2]